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1. Introduction 
Composite materials may be restricted to emphasize those materials that contain a 
continuous matrix constituent that binds together and provides form to an array of a 
stronger, stiffer reinforcement constituent. The resulting composite material has a balance of 
structural properties that is superior to either constituent material alone. Combining the 
advantages of inorganic and organic components such as HA/organic composites that show 
good biocompatibility and favorable bonding ability with surrounding host tissues inherent 
from HA. Besides, the problems associated with HA ceramic, such as its intrinsic brittleness, 
poor formability and migration of HA particles from the implanted sites, can be 
circumvented by the integration of HA ceramic with biopolymers. In order to achieve 
controlled bioactivity and biodegradability, polymer-ceramic composites have been 
proposed. The composites of ceramics with natural degradable polymers have attracted 
much interest as bone filler. Several particle composites based on degradable biopolymers 
such as chitosan and gelatin with inorganic powders, were developed as bone filler. 
2. Hydroxyapatite (HA) 
Hydroxyapatite (HA) (Ca10 (PO4)6(OH)2, is widely used in musculoskeletal procedures due 
to its chemical and crystallographic similarity to the carbonated apatite in human bones and 
teeth (Suchanek and Yoshimura, 1998). While sintered HA can be machined and used in 
pre-fabricated forms, several formulations of calcium phosphate cements can be molded as 
pastes and harden in situ. HA is the main component of teeth and bones in vertebrates. 
Good mechanical properties with superior biocompatibility of sintered HA make it well 
preferred bone and tooth implant material (Kim et al., 2008). Calcium phosphates, especially 
HA, are excellent candidates for bone repair and regeneration and have been used in bone 
tissue engineering for two decades. Although HA is bioactive and osteoconductive, its 
mechanical properties are inadequate, making it unable to be used as a load bearing 
implant.  
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2.1. Properties 
HA power (HAp), a major inorganic component of bone, has been used extensively for 
biomedical implant applications and bone regeneration due to its bioactive, biodegradable 
and osteoconductive properties (Gomez-Vega et al., 2000). HA is available in market in 
many forms like solids blocks, micro-porous blocks and as granules (Murgan and 
Ramakrishna, 2005). Nano-hydroxyapatite (n-HA) has been proven to be of great biological 
efficacy. nHA precipitates may have higher solubility and therefore affect the biological 
responses. It was able to promote the attachment and growth of human osteoblast-like cells 
(Huang et al., 2004). Clinical trials have shown that HA cement is both biocompatible and 
resistant to infection and that the HA coating improves the success rate of implants. It has 
also been demonstrated that HA ceramics support mesenchymal stem cell (MSC) 
attachment, proliferation, and differentiation (Zhao et al., 2006). Nano scaled HA with 
extraordinary properties such as high surface area to volume ratio and ultra fine structure 
similar to that of biological apatite, which is of great effect on cell-biomaterial interaction, 
has been reported to be used for the treatment of bone defects, and it could bond to living 
bone in implanted areas (Liuyun et al., 2008). HAp has been used in bone regeneration and 
as a substitute of bone and teeth because it is a biocompatible, bioactive, non-inflammatory, 
non-toxic, osteoconductive and non-immunogenic material (Grande et al., 2009).  
Instability of the particulate nHA is often encountered when the particles are mixed with 
saline or patient’s blood and hence migrate from the implanted site into surrounding tissues 
and causing damage to health tissue (Miyamato and Shikawa, 1998). Also, HA ceramic is 
difficult to shape in specific forms required for bone substitution, due to its hardness and 
brittleness. Therefore, a composites of HAp and organic polymers have become of great 
interest to compensate the weak mechanical points of HAp (Furukawa et al., 2000). 
Mohamed and Mostafa, (2008) reported that HA has low fracture toughness, hardness and 
brittleness, therefore, HA cannot serve as a bulk implant material under the high 
physiological loading conditions traditionally associated with implants.  
Since the natural bone is a composite mainly consisted of nano-sized, needle-like HAp 
crystals and collagen fibers, many efforts have been made to modify HAp by polymers, such 
as poly-lactic acid (Kasuga et al., 2001), chitosan (Viala et al., 1998), polyethylene (Wang and 
Bonfield, 2001) to compensate the weak mechanical points of HAp. Yamaguchi et al., (2003) 
reported that chitosan is flexible and has a high resistance upon heating due to the intra-
molecular hydrogen bonds formed between hydroxyl and amino groups. A composite 
biomaterial of HAp and chitosan is, therefore, expected to show an increased 
osteoconductivity and biodegradation together with a sufficient mechanical strength for 
orthopedic use. A major disadvantage of current orthopedic implant materials such as 
sintered hydroxyapatite is that they exist in a hardened form, requiring the surgeon to drill 
the surgical site around the implant or to carve the graft to the desired shape. This can lead 
to increases in bone loss, trauma, and surgical time. Hence, the moldable, self-setting 
calcium phosphate cement (CPC)-chitosan composite is desirable for dental, craniofacial and 
orthopedic repairs, especially where shaping and contouring for esthetics are needed. The 
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CPC powder can be mixed with the chitosan liquid to form a paste that can be applied in 
surgery via minimally invasive techniques such as injection, with fast-setting and anti-
washout capabilities to form a scaffold in situ (Moreau and Xu, 2009).  
2.2. Applications 
Bone defects that are generated by tumor resection, trauma, and congenital abnormality 
have been clinically treated by the implantation of bioceramics or autogenous and 
allogenous bone grafts. Although autografting is a popular procedure for reconstructive 
surgery, it has several disadvantages, such as the shortage of donor supply, the persistence 
of pain, the nerve damage, fracture, and cosmetic disability at the donor site. On the other 
hand, there are no donor site problems for allografting, while allografting has some clinical 
risks including disease transmission and immunological reaction (Takahashi et al., 2005). 
HA has been incorporated into a wide variety of biomedical devices including dental 
implants, coatings on Ti based hip implants, biodegradable scaffolds, and other types of 
orthopedic implants (Wilson and Hullb, 2007). Synthetic HA, is a bioactive material that is 
chemically similar to biological apatite HA, has been used as a bioactive phase in the 
composites, coating on metal implants, and granular filler for direct incorporation into 
human tissues (Rehman et al., 1995). The characteristics of an ideal ceramic composite for 
bone tissue engineering should comply to the following parameters:(1) A biodegradability 
for bone remodeling, (2) A macroporosity for in-growth into the composite, (3) Mechanical 
stability/ease of handling, (4) Osteoconductivity to guide bone around/inside the implant, 
(5) Carrier for growth factors/cells. The use of these materials for tissue engineering 
purposes is still explored. Most researchers are aware that HA has low resorbability of 
sintered Ca P-ceramics. Because of the positive influence of ceramics on cell 
differentiation/proliferation, it is not surprising that bone forming cells are introduced into 
these ceramics to speed-up tissue in-growth. The surface of sintered ceramics is chemically 
stable and therefore a good substrate for seeding cells. In the field of bone tissue engineering 
most scaffolds are ceramic or ceramic-derivatives. Especially HA-based calcium phosphate 
compound is regarded as high-potential scaffolds due to their osteoconductive properties. 
Next to the scaffold material, in bone tissue engineering, cells and growth factors are also 
introduced to speed-up tissue in-growth. In most ceramic scaffolds, however, difficulties 
arise when cells are added, most probably due to a limited supply of nutrition at the inside 
of the implant or less than optimal cell-cell interactions. Growth factors like bone 
morphogenic protein-2 (BMP-2), transforming growth factor (TGF-β), basic fibroblast 
growth factor (b-FGF) and vascular endothelial growth factor (VEGF) are commonly 
introduced into these scaffolds due to their osteoinductive properties and vascularization 
(Habrakenb et al., (2007). HA has a composition and structure very close to natural bone 
mineral and therefore has been considered to be the ideal material to build bone tissue 
engineering scaffold due to its osteoconductivity and osteoinductivity (Wang et al., 2007). 
Some in vitro studies demonstrated that nano-phase HA (67 nm grain size) significantly 
enhanced osteoblast adhesion and strikingly inhibited competitive fibroblast adhesion 
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compared to conventional, 179 nm grain size HA, after just 4 h of culture. Researchers 
believe they know why they have elucidated the highest adsorption of vitronectin (a protein 
well known to promote osteoblast adhesion) on nanophase ceramics, which may explain the 
subsequent enhanced osteoblast adhesion on these materials. In addition, enhanced 
osteoclast-like cell functions (such as the synthesis of tartrate-resistant acid phosphatase 
(TRAP) and the formation of resorption pits) have also been observed on nano-HA 
compared to conventional HA, nano-porous or nano-fibrous polymer matrices can be 
fabricated via electrospinning, phase separation, particulate leaching, chemical etching and 
3-D printing techniques (Zhang et al., 2008). 
3. Chitosan polymer (C) 
3.1. Structure 
Brimacombe and Webber, (1964) reported that the chitosan consists of repeating units of 
beta (1-4) 2-amino-2-deoxy-D-glucopyranon (D-glucosamine) (Fig.1). The primary unit of 
chitin is 2-acetamido-2-deoxy-D-glucose, while that of chitosan is 2-amino-2-deoxy-D-
glucose with beta, 1-4 glucosidic linkages (Muzarelli, 1985). Chitosan is a natural 
polysaccharide derived from chitin by its deacetylation (Dang and Leong, 2006). Chitosan 
shares a number of chemical and structural similarities with collagen. These similarities 
form the basis for the development of HAp/chitosan nano-composites for use in bone tissue 
engineering (Wilson et al., 2007 
 
Figure 1. Structure of chitosan 
3.2. Origin  
The history of chitosan dates back to the 19 th century, when Rouget, 1859 discussed the 
deacetylated form of chitosan. Chitin, the source material for chitosan, is one of the most 
abundant organic materials, being second only to cellulose in the amount produced 
annually by biosynthesis. It is an important constituent of the exoskeleton in animals, 
especially in crustacean, molluscs and insects. It is also the principal fibrillar polymer in the 
cell wall of certain fungi (Eugene and Lee, 2003). Chitosan is one of the most abundant 
naturally occurring polysaccharides, primarily obtained as a sub-product of seafood, 
containing amino and hydroxyl groups (Muzarelli, 1985 and Manjubala et al., 2006).  
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3.3. Properties 
3.3.1. Physical and chemical properties 
The size of chitosan molecule plays an important role in drug delivery system where the 
release rate was reported to be inversely proportional to the molecular weight of the 
reservoir. Chitosan is insoluble in water, alkali and many organic solvents but soluble in 
many dilute aqueous solutions of organic acids, of which most commonly used are formic 
acid and acetic acid. Tomihata and Ikada, (1997) concluded that molecular weight of 
chitosan affect the crystal size and morphological character of its cast film. Gorbunoff, (1984) 
concluded that the chemical interaction between NH3+ and HPO42- control the adsorption of 
chitosan on octacalcium phosphate (OCP) crystal surface which is similar to the binding of 
protein to the surface of apatite crystals. Chitosan permeability increased in the amorphous 
region of the membrane (Brine, 1984). Chitosan forms a polycation in aqueous acid solutions 
like acetic acid and hydrochloric acid via protonation of amine functions (Muzarelli, 1985).  
Blair et al., (1987) reported that chitosan prepared from crab shell chitin has a lower 
molecular weight than that prepared from prawn shells and tensile strength versus 
elongation decrease at the break with prolonged treatment in alkali solutions and both 
increase proportional to higher molecular weight. Also, crystallinity of membrane increased 
with decreasing molecular weight of chitosan and it is hydrophilic i.e it contains a large 
number of OH groups which are easy to combine with another group and form new bond 
(Ogawa et al., 1992). The larger molecular weight of chitosan used, the higher tensile 
strength and higher tensile elongation of membrane were obtained (Chen and Hwa, 1995). 
The degree of deacetylation affects the physical properties of chitosan membrane and it does 
not change during ultrasonic degradation on chitosan. The molecular weight of the 
prepared chitosan depends on the severity of the deacetylation process.  
Chitosan is flexible and has a high resistance upon heating due to the intra-molecular 
hydrogen bonds formed between hydroxyl and amino groups (Lee et al., 1999). The 
degradation rate is inversely related to the degree of crystallinity which is controlled mainly 
by the degree of deacetylation (DD). Highly deacetylated forms (85 %) exhibit relatively a 
low degradation rate and may take several months in vivo, whereas, the forms with lower 
DD degrade more rapidly. The degradation rates also inherently affect both the mechanical 
and solubility properties (Kamiyama et al., 1999).  
The cationic nature of chitosan also allows for pH-dependent electrostatic interactions with 
anionic glycosaminoglycans (GAG) and proteoglycans distributed widely throughout the 
body and other negatively charged species. This property is one of the important elements 
for tissue engineering applications because numbers of cytokines/growth factors are known 
to be bound and modulated by GAG including heparin and heparin sulfate (Nishikawa et 
al., 2000). Chitosan is easy to handle for its resistive nature to heating due to intra-molecular 
hydrogen bonds between hydroxyl and amino groups (Itoh et al., 2003). Chitosan is a very 
versatile biopolymer with film, fiber, and micro/nanoparticle forming properties. It is 
biocompatible, biodegradable and non-toxic (Yilmaz, 2004). Deacetylation of chitin with a 
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degree of deacetylation more than 50 % gives chitosan, which is soluble in organic acids 
such as acetic or formic acid, and has been more widely used than chitin as films, 
membranes, fibres and particles ( Kang et al., 2006). Chitosan has three types of reactive 
functional groups, an amino group as well as both primary and secondary hydroxyl groups 
at the C(2), C(3), and C(6) positions, respectively. These groups allow modification of 
chitosan like graft copolymerization for specific applications, which can produce various 
useful scaffolds for tissue engineering applications. The chemical nature of chitosan in turn 
provides many possibilities for covalent and ionic modifications that allow extensive 
adjustment of mechanical and biological properties (Kim et al., 2008). When the temperature 
is 30°C, the crystallinity of chitosan membrane is relatively high and its crystal particles are 
much small, which makes the mechanical properties poor. When the temperature is as high 
as 90°C, the temperature will cause the change of chitosan properties and the chitosan 
membrane is nearly not a crystal structure at this moment, resulting in the fall of mechanical 
properties (Xianmiao et al., 2009).  
3.3.2. Biological properties 
Chitosan potentiates the differentiation of osteoprogenitor cells and may facilitate the 
formation of bone. Rao and Sharma, (1997) concluded that chitosan is an ideal non-toxic 
biopolymer and the cell binding and cell activating properties of chitosan play a crucial role 
in its potential action. Chitosan degrades in the body to non-harmful and non-toxic 
compounds and has been used in various fields such as nutrition, metal recovery and 
biomaterials (Muzzarelli et al., 2001). It has gained much attention as a biomaterial in 
diverse tissue engineering applications due to its low cost, large-scale availability, anti-
microbial activity, and biocompatibility (Khora and Limb, 2003). Chitosan was suggested as 
an alternative polymer for use in orthopedic applications to provide temporary mechanical 
support to the regeneration of bone cell in-growth due to its good biocompatible (Khora and 
Limb, 2003), non-toxic, biodegradable and inherent wound healing characteristics (Eugene 
and Lee 2003). Chitosan had been used in various forms such as zero dimension 
microsphers, two-dimension membrane, three-dimension pin or rod (Hu et al., 2003). 
Therefore, much attention has been paid to chitosan-based biomedical materials, for 
instance, as a drug delivery carrier or a wound-healing agent. Chitosan is structurally 
similar to glycosaminoglycan (GAG) and has many desirable properties as tissue 
engineering scaffolds (Kuma, et al., 2004). It was reported as being neither antigenic in 
mamalian test system nor thrombogenic and chitosan reported to improve hemostasis, 
decreased fibroplasias with enhanced tissue organization as well as normal bone formation 
(Mohamed, 2004). Chitosan marginally supports biological activity of diverse cell types 
(Sarasam and Madihally, 2005).  
A number of natural and synthetic polymers have been studied for overcoming the weak 
points as bone substitutes. Chitosan has been found in a broad spectrum of applications 
along with unique biological properties including biocompatibility, biodegradability to 
harmless products, non-toxicity, physiological inertness, remarkable affinity to proteins, 
antibacterial, haemostatic, fungi-static, anti-tumoral and anti-cholesteremic properties (Kim 
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et al., 2008). Chitosan has been shown to degrade in vivo, which is mainly by enzymatic 
hydrolysis. The degradability of a scaffold plays a crucial role on the long-term performance 
of tissue-engineered cell/material construct because it affect many cellular process, including 
cell growth, tissue regeneration, and host response. If a scaffold is used for tissue 
engineering of skeletal system, degradation of the scaffold biomaterial should be relatively 
slow, as it has to maintain the mechanical strength until tissue regeneration is almost 
completed. Lysozyme is the primary enzyme responsible for in vivo degradation of 
chitosan, which appears to target acetylated residues (Kim et al., 2008).  
3.4. Applications 
Chitosan of biopolymer have been used as blood coagulant, in artificial kidney membrane, 
digestive sutures, hypercholesterolemic agents, media for the slow release of drugs and 
hemostatic agent (Mohamed, 2004). It is a good candidate for biomedical applications such 
as for wound healing, vaccine delivery, as well as tissue regeneration (Yilmaz, 2004). It has 
been extensively investigated in biotechnological, biomedical, and environmental fields 
(Dang and Leong, 2006). Chitosan polymer is used in dentistry, because it prevents the 
formation of plaque and tooth decay. Since chitosan can regenerate the connective tissue 
that covers the teeth near the gums, it offers possibilities for treating periodontal diseases 
such as gingivitis and periodontitis (Elizalde-Pen et al., 2007).  
3.4.1. Membrane 
Aiba et al., (1986) used chitosan in membrane separation, chemical engineering, medicine 
and biotechnology areas. It was also found that the water adsorption and the mechanical 
properties of fibroin membrane were improved by blending chitosan (Chen et al., 1998). 
3.4.2. Skin  
Muzzarelli et al., (1988) used chitosan as artificial skin substitute and they reported that no 
adverse effect after implantation in tissue. In general, these materials have been found to 
evoke a minimal foreign body reaction, with little or no fibrous encapsulation. It observed 
the typical course of healing with formation of normal granulation tissue, often with 
accelerated angiogenesis (Suh and Matthew, 2000). Also, chitosan has many advantages for 
wound healing such as hemostasis, accelerating the tissue regeneration and stimulating the 
fibroblast synthesis of collagen (Mi et al., 2001). Chitosan possesses the properties favorable 
for promoting rapid dermal regeneration and accelerate wound healing suitable for 
applications extending from simple wound coverings to sophisticated artificial skin matrices 
(Kim et al., 2008).  
3.4.3. Bone substitutes 
Sapelli et al., (1986) used chitosan powder to promote healing of periodontal pockets, palatal 
wounds and extraction sites. Malette et al., (1986) proved enhanced leg bone regeneration in 
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dogs using chitosan. It was reported to accelerate wound healing and was applied for bone 
wound repair in dogs (Borah et al., 1992) as well as bone growth in critical size metacarpal 
fibular defects. Klokkevold et al., (1992) concluded that chitosan solution may enhance the 
formation of bone. Later, it was reported to improve osseous healing of defects in femoral 
coundyl of sheep and stimulated cell proliferation and organized the hystoarchitectural 
tissue structure (Muzzarelli et al., 1994). Chitosan has been also extensively used in bone 
tissue engineering since after exploring its capacity to promote growth and mineral rich 
matrix deposition by osteoblasts in culture. Also, chitosan is biocompatible (additional 
minimizes local inflammation), biodegradable, and can be molded into porous structures 
(allows osteoconduction) (Martino et al., 2005 and Kim et al., 2008).  
3.4.4. Drug delivery system (DDS) 
Chitosan as an inert and hydrophilic material, its gel is suitable for application as matrices 
for enzyme/cell immobilization (Roberts, 1992) and for separation processes (Li et al., 1992). 
Felt et al., (1998) discussed the use of chitosan to manufacture sustained release systems 
deliverable by other routes such as nasal, ophthalmic, transdermal and implantable devices. 
Tarsi et al., (1998) suggested that low molecular weight chitosan may be very interesting as 
potential antidental caries agents. Chitosan has been reported to enhance drug delivery 
across the nasal or mucosal layer without damage (van der Lubben et al., 2001). The 
selectivity of membrane is a critical parameter in membrane separation and several factors 
are affecting its selectivity such as pore size, thus it is very suitable for the use as DDS and in 
artificial kidney (Mohamed, 2004). The cationic properties of chitosan offer valuable 
properties for drug delivery systems, gene delivery systems, and tissue engineering, that is, 
the formation of ion complexes between chitosan and anionic drugs or DNA can be used as 
a delivery vehicle (Kim et al., 2007).  
3.4.5. Anti-bacterial 
The experiments of antibacterial activity of chitosan-graft-polyethylene terephthalate (PET) 
against S. aureus showed a high growth inhibition in the range of 75–86% and still maintained 
a 48–58% bacterial growth inhibition after laundering (Hu et al., 2003). Chitosan and chito-
oligosaccharides grafted membranes showed antibacterial activity against Escherichia coli, 
Pseudomonas aeruginosa, methicilin-resistant Staphylococcus aureus (MRSA), and S. aureus 
(Hu et al., 2003). Chitosan is a biomaterial with antiseptic property and the influence of the 
release or positive migration of protonated glucosamine fractions from the biopolymer into 
the microbial culture is the responsible event for the antimicrobial performance of the 
biopolymer (Beherei et al., 2009). 
3.4.6. In-vitro application 
Chitosan and collagen have intrinsic properties that support growth and differentiation of 
osteoblasts. Collagen was combined with chitosan and cross-linked to improve the biological 
stability and strength of chitosan–collagen composite sponges to reach the demand of an 
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application in bone tissue engineering. The incorporation of chitosan into a collagen scaffold 
increases the mechanical strength of the scaffold and reduces the biodegradation rate against 
collagenase (Arpornmaeklong et al., 2007).  
 
Figure 2. Cell viability of osteoblasts cultured for 21 days on the sponges (Arpornmaeklong et al., 2007). 
The collagen, chitosan and chitosan–collagen sponges were biocompatible. All sponges 
supported growth of cells on three-dimensional structures in a similar manner. Chitosan 
sponges had a tendency to promote growth of cells to a greater extent than the other groups 
(Fig.2). It is postulated that strong attraction between positive charges on the chitosan 
surface and negative charges on the cell surface enhanced the metabolic activity of cells on 
chitosan sponges (Mi et al., 2001). In vivo, chitosan enhances angiogenesis and wound 
healing, and supports growth and differentiation of osteoblasts (Lee et al., 2004).  
3.4.7. Other applications  
a) Blood vessels:The chitosan fibers offer the potential of being fabricated into blood vessels 
and their blood compatibility results demonstrated for applications where 
hemocompatibility is required (Khora and Limb, 2003). Kim et al., (2008) reported that the 
effort has made to overcome both incomplete endothelialization and smooth muscle cell 
hyperplasia, which are two of the problems contributing to the poor performance of existing 
small-diameter (4 mm) vascular grafts, through complexation of GAGs with porous chitosan 
scaffolds. GAG-based material should promise because of their growth inhibitory effects on 
vascular smooth muscle cells and their anti-coagulant activity. However, few data regarding 
chitosan as a scaffold of tissue engineered blood vessels have been reported. Chitosan itself 
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was documented to promote migration of endothelial cells and fibroblasts so as to accelerate 
wound healing. b) Nerve: Chitosan has been studied as a candidate material for nerve 
regeneration due to its properties such as antitumor, antibacterial activity, biodegradability 
and biocompatibility. Neurons that were cultured on the chitosan membrane can grow well 
and that chitosan tube can greatly promote the repair of the peripheral nervous system, also 
the chitosan fibers supported the adhesion, migration and proliferation of Schwann cells 
(SCs), which provide a similar guide for regenerating axons to Büngner bands in the 
nervous system (Yuan et al., 2004). c) Liver: Chitosan as a promising biomaterial can be 
applied in liver tissue engineering due to its various properties such as its structure that is 
similar to glycosamineglycans (GAGs), which are components of the liver extracellular 
matrix (ECM) (Li et al., 2003). d) Cartilages: Chitosan is one of the most abundant 
polysaccharides and thus shares some bioactivities with various glycosaminoglycans and 
hyaluronic acid present in articular cartilage (Suh and Matthew, 2000). Lu et al., 1999 has 
demonstrated that the chitosan solution injected into the knee articular cavity of rats lead to 
a significant increase in the density of chondrocytes in the knee articular cartilage, indicating 
that chitosan could be potentially beneficial to the wound healing of articular cartilage (Lee 
et al., 2004).  
4. Bone structure 
Bone is a specialized tissue comprising mineral substances, organic tissue, and water (Otto 
et al., 1997). Cortical bone is largely a composite of collagen, fiber and biological apatite 
(Fricain et al., 1998). The inorganic component of bone (bone mineral) is calcium phosphate 
that contains up to 8 wt% carbonate. Substitution of carbonate or other ions HA can occur in 
two distinct atomic sites in the lattice (Suchanek et al., 2002). These ions can partially 
substituted in the lattice for hydroxyl ions (OH), known as the A site, and/or for phosphate 
ions, known as the B site (Gibson and Bonfield, 2002). Skeletal bone is of two types: cortical 
bone and trabecular bone. Cortical bone is the outermost mineralized cortex. It is compact, 
strong, and densely packed as an intricate calcium matrix. Cortical bone comprises 85% of 
the skeleton, specifically 75% in the femoral neck, 75% in the distal radius, and 95% in the 
midradius. Cortical bone has no contact with marrow. Trabecular bone is the inner spongy 
structure composed of the sturdy collagen matrix. It comprises 15% of the skeletal mass and 
has structural rigidity and elasticity to withstand mechanical stress. Trabecular bone 
contains hematopoietic tissue in its central cavity. The bone of diaphysis consists of 
cancellous bone covered with a shell of cortical bone (Fig.3). The flat bones of the skull have 
a middle layer of cancellous bone sandwiched between two relatively thick layers of cortical 
bone (Liu et al., 2009). 
Bone remodeling occurs continuously throughout the lifetime, although the process slows 
with age. The balance of osteoclastic and osteoblastic activity results in breakdown and 
reconstruction, which ensures skeletal integrity and maintains mineral homeostasis. 
Osteoclasts and osteoblasts are interconnected and influence the activity of each other. 
Osteoclasts are large multinuclear cells that develop from monocyte-macrophage 
precursors. They are imbedded in the bone matrix at or near the site of bone resorption and 
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dissolve first the calcium and then the organic matrix of the bone. Osteoblasts arise from 
mesenchymal cells and are found layered over the bone. They deposit calcium into the 
matrix that is building up cortical bone and produce collagen and other proteins to 
synthesize the bone matrix. Osteoclasts that are in close proximity can increase sensitivity of 
osteoblasts to growth factors. When a bone is broken there is usually bleeding into the space 
between the bone and the periosteum. This produces a hematoma, swelling due to blood. 
The osteoblasts, bone-producing cells, near the hematoma invade it along with small blood 
vessels from the bone. In a short time, the hematoma is replaced by bone tissue produced by 
the osteoblasts. In general, this bone is cancellous, but the added bone makes the broken 
junction much thicker than it was. The swollen bone is called the callus. A remarkable 
process follows. Where there is strain, the newly formed cancellous bone condenses into 
compact bone. Where strain is absent, the cancellous bone disappears through the activity of 
osteoclasts, bone destroying cells. This process seems to determine the development of the 
skeleton in normal growth (Roodman, 2004).  
 
Figure 3. Bone structure 
5. Hydroxyapatite/chitosan biocomposites: Introduction 
For the increase of bioactivity and mechanical property, some composites of polymer and 
bioactive ceramics have been developed for bone tissue engineering. These composites fulfill 
the mechanical properties required for their function as skeleton, teeth and cells of organisms. 
Among these composites, HAp/polymer composites have attracted much attention since such 
composites may have osteconductivity due to the presence of HAp, which has a similar 
chemical composition and structure to the mineral phase of human bones and hard tissues. 
Thus, HA/polymer composite scaffolds are of interest for biomedical applications (Jin et al., 
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2008). Kikuchi et al., (2004) prepared a self organized HA-collagen nano-composite by a 
biomimetic co-precipitation method. It was reported that the composite had similar 
microstructure to native bone and showed osteoclastic resorption and good osteoconductivity. 
However, a major concern over HA-collagen composite is the high cost of collagen, which 
limits its clinical application in healing bone defect to its insouciant formability and flexibility. 
Polymers such as chitosan have a higher degradation rate than bioceramics. Incorporation of 
HA into a chitosan polymer matrix has been shown to increase osteoconductivity and 
biodegradability with significant enhancement of mechanical strength (Yamaguchi et al., 
2001). Chitosan’s primary attractive features including its biocompatibility, biodegradability, 
flexibility, adhesiveness and anti-infectivity, make it as a feasible wound healing agent and an 
ideal polymeric matrix for HA ceramic (Rusu et al., 2005).        
5.1. Structure 
The free amino groups of chitosan (C-NH2) was protonated to C-NH3+, when chitosan was 
dissolved in acetic acid (HAc) solution, which was shown as follows: 
2 3C NH HAc C NH +Ac  pH 4.2
      
The presence of calcium and phosphate ions in chitosan solutions leads to formation of 
HA\chitosan composites through electrostatic interactions between C-NH3+ and Ca2+ 
and\or PO43- ions to form C-Ca and C-PO4 complexes. There is also an interaction between 
OH of chitosan and OH of HA via hydrogen bond (Hu et al., 2004).  
5.2. Properties 
Chitosan can be utilized in combination with other bioactive inorganic ceramics, especially 
HA to further enhance tissue regenerative efficacy and osteoconductivity. Incorporation of 
HA with chitosan, the mineral component of bone, could improve the bioactivity and the 
bone bonding ability of the chitosan/HA composites (Wang et al., 2002). Chitosan just plays 
in a role of adhesive to dissolve the problem of difficulty of HA specific shape and migration 
of HA powder when implanted. HA/chitosan nano-composites are prepared by the 
precipitation. It is proposed that the nano-structure of HA/chitosan composite will have the 
best biomedical properties in the biomaterials applications (Chen et al., 2002). Also, it has 
been demonstrated that chitosan-hydroxyapatite composite induces osteoconductivity in 
osseous defects and could act as drug vehicle. It is important to be able to load these 
composites with short-time life and controlled action anti-inflammatory to reduce or 
eliminate undesirable inflammatory processes (Larena et al., 2004).         
It is desirable to develop a composite material with favorable properties of chitosan and HA. 
The designed composites are expected to have an optimal mechanical performance and a 
controllable degradation rate as well as eminent bioactivity and this will be of great 
importance for bone remodeling and growth (Zhang et al., 2005). It must be emphasized at 
this point that the successful design of a bone substitute material requires an appreciation of 
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the structure of bone. Thus, the use of a hybrid composite that makes up of chitosan and 
calcium phosphate resembles the morphology and properties of natural bone. This may be 
one-way to solve the problem of calcium phosphates brittleness, besides possessing good 
biocompatibility, high bioactivity and great bone-bonding properties (Ding, 2007). The 
mechanical strength of the chitosan/calcium phosphate composite fiber with core-shell 
structure increased with an increased concentration of chitosan solution (Matsuda et al., 
2004). Among the composites studied, the 30/70 chitosan/n HA exhibits the maximum value 
of compressive strength, about 120 MPa, which is strong enough to be used in load-bearing 
sites of bone tissue. In contrast the compressive strength of pure HA compact prepared by 
the similar method has been reported as 6.5 MPa about one twentieth of the maximum value 
of the composite. In general, the proper stress transfer occurring between the reinforcement 
and the matrix governs the mechanical characteristics of filled polymers. The chemical and 
mechanical interlocking between n-HA and chitosan are accounts for the efficient stress-
transfer in the composite system. Besides, the interactions such as hydrogen bonding and 
chelation between the two phases, also contribute to the good mechanical properties of 
chitosan/n-HA composite (Zhang et al., 2005). The biodegradable composites based on 
chitosan and calcium phosphate have been prepared using a simple mixing and heating 
method. The detrimental effects of the simulated physiological environment on mechanical 
properties of the hybrid composites resulted in the significantly decrease in strength and 
modulus. The chitosan/calcium phosphate composites containing 10 wt/v % might an 
optimal material in terms of initial strength and degradation behavior. Although 
susceptibility to solution attack, this type of chitosan/calcium phosphate composites with 
high initial strength might be acceptable for use in bone tissue repair (Ding, 2007).    
Three-dimensional biodegradable chitosan/nHA composite scaffolds were characterized by 
superior mechanical, physicochemical, and biological properties compared to pure chitosan 
scaffolds for bone tissue engineering. The nanocomposite scaffolds were characterized by a 
highly porous structure and the pore size was similar for scaffolds with varying n-HA 
content. The nano-composite scaffolds exhibited greater compression modulus, slower 
degradation rate and reduced water uptake, but the water retention ability was similar to 
that of pure chitosan scaffolds. Favorable biological response of pre-osteoblast on 
nanocomposite scaffolds included improved cell adhesion, higher proliferation, and well 
spreading morphology in relation to pure chitosan scaffold (Thein-Han and Misra, 2009). 
Mechanical properties of biocomposites: hydroxyapatite/chitosan (HA/CS) nano-composite 
rods were reinforced via a covalently cross-linking method. The bending strength and 
bending modulus of the cross-linked HA/CS (5/100, wt/wt) rods could arrive at 178 MPa 
and 5.2 GPa, respectively, increased by 107% and 52.9% compared with uncross-linked 
HA/CS (5/100, wt/wt) rods (Takagi et al., 2003). The presence of HA-DBM filler into the 
grafted chitosan copolymer matrix resulted in compressive strength properties are quite 
close to those of cancellous bone (2–12 MPa). This result is due to effect of the presence of 
demineralized bone matrix (DBM) powder and pMMA having bone cement formation 
within this composite (Mohamed et al., 2007). The E-modulus and compressive strength for 
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the three composites HA/, 90%HA-10Ti/, and 70%HA-30%Ti/grafted chitosan copolymer 
composites recorded comparable values compared to the cancellous bone. Therefore, the 
presence of HA filler or HA filler containing titania content up to 30% into the copolymer 
resulted in compressive strength properties that are quite close to those of cancellous bone 
(2–12 MPa) (Mohamed et a., 2008).  
Collagen/apatite composite membranes exhibited significantly improved mechanical 
properties compared with their pure collagen equivalent; their mechanical properties were 
still lower than those of natural bone (Teng et al., 2009). It was notified that hardness of 
calcium pyrophosphate (CPP)/ chitosan composite (66.80) was increased compared to 
chitosan copolymer (60.88) and the hardness of CPP/chitosan-grafted composite (68.23) was 
also increased compared to chitosan–gelatin copolymer (84.12) proving the polymer/filler 
interaction and adhesion. Also, the compressive strength of CPP/chitosan composite (6.53 
MPa) was increased compared to chitosan copolymer (5.11 MPa). These values of 
compressive strength were comparable to those of human cancellous bone (Kokubo et al., 
2003). As a result, CPP filler powder into the chitosan copolymer matrix containing chitosan 
or chitosan–gelatin polymer resulted in more effective reinforcement of the composite, then, 
stiffer composite (El-Kady et al., 2009). The CPC–chitosan composites were more stable in 
water than conventional calcium phosphate cement (CPC). They did not disintegrate even 
when placed in water immediately after mixing. The CPC–chitosan paste hardened within 
10 min in all cases. The authors demonstrated that CPC–chitosan composites are stable in a 
wet environment and have acceptable mechanical strengths for clinical applications (Wang 
et al., 2010). 
5.3. Preparation 
Although powder ceramics remain the form of choice for filling small irregular defects, the 
therapeutic effect of the filling implant was lost by migration of particles from the defect 
site. Furthermore, it was difficult to be handled and kept in place compactly for convenient 
fabrication and operation of block-type ceramics (Lin et al., 1998). Thus, it is necessary to 
mix a suitable binder with the granular material to overcome these problems. Presently, the 
approaches to obtain chitosan/hydroxyapatite (HAp) composite materials are based either 
on mixing or co-precipitation methods. Yamaguchi et al., (2001) have developed one of the 
co-precipitation methods that lead to a type of chitosan/HAp composites. In this approach, 
the composite was co-precipitated in one step, by dropping a chitosan solution containing 
phosphoric acid into a calcium hydroxide suspension. Other approaches employ either the 
biomineralization of chitosan in a solid form (especially as membranes) in simulated body 
fluids (SBF) (Beppu and Santana, 2001) or by mixing of a chitosan solution with different 
calcium phosphate fillers followed by their precipitation as hydrogel composite. The use of 
these approaches leads to incorporation of inorganic fillers into the structure of composites 
(Schwarz and Epple, 1998), either as nano-sized or micro-sized particles.  
Different preparation methods of HAp/chitosan composites have been reported, such as 
mechanical mixing of HAp powder in a chitosan solution, coating of HAp particles onto a 
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chitosan sheet, coating of HAp crystals onto a tendon chitosan (Yamaguchi et al., 2003) and 
a co-precipitation method. The chitosan/HAp hybrid fiber has also been reported by Chung 
and Korean, (2002). However, these materials were shown in the macroscopically 
homogeneous. The conventional method to fabricate chitosan/HA composite is that HA 
powder was mixed with chitosan, dissolved in 2% acetic acid solution, then the mixture was 
impressed into mold, finally was freezing-dried to make sponge composite. Surface 
modification and polyblend methods can be used to change the physicochemical properties 
of chitosan–gelatin membranes or scaffolds by incorporating hyaluronic acid. Adding 
hyaluronic acid can improve the mechanical, biological and anti-degradation properties of 
the membranes or the scaffolds (Mao et al., 2003). 
Hydroxyapatite (HAp) was prepared by precipitation method, while the biphasic 
hydroxyapatite/tricalcium phosphate (HA/B-TCP) was prepared by heating the prepared 
HAp at 900°C for 5 hours in air. To improve bioactivity both HAp and HAp/TCP fillers were 
loaded onto chitosan grafted with two monomers, hydroxyethylmethacrylate (HEMA) and 
methylmethacrylate (MMA) during copolymerization process (Hashem and Mohamed, 
2007). Also, biocomposites containing HA-DBM mixture powder loaded onto the copolymer 
matrix containing the grafted chitosan with poly methylmethacrylate (pMMA) and its 
derivative during copolymerization were fabricated (Mohamed et al, 2007).  
The chitosan mineralization in the case of using a stepwise co-precipitation approach involves 
the following stages: First, chitosan chains change their conformation as a function of 
environmental parameters, such as pH. Starting from extended conformations such as worm-
like, as seen in Fig.4 (1), adopted at low pH (until 3–3.5), chitosan turns to the more compact 
conformations such as extended random coil Fig.4(2) and even to more compacted random 
coil conformations, at higher pH values (from 3.5 until 6). Between 5.5 (the pH at which 
brushite is precipitated) and 6.5–6.7 (the pH at which chitosan is precipitated) is the pH range 
that leads to formation of an interconnected three-dimensional net work between chitosan and 
brushite that can be approximated as a dendritic-like structure, as shown in Fig.4(3). This 
structural model is characterized by highly dense irregular shaped cores which are linked by 
the chitosan bridging segments. In the dendritic core, the chitosan chains are randomly packed 
as amorphous regions while in the bridging regions more extended conformations are found, 
in some parts parallel oriented chains domains are presented. Since the dendritic core is in the 
range between 200 and 600nm hence it is formed by the many compact random coil chitosan 
units that are approaching one another chitosan chain segments can interact with the CaPs 
phases (i.e. seeds of HAp already formed at pH 5.5 and identified by its XRD pattern, brushite 
and some other ACP). In this way, they achieve of so called ‘‘anchoring regions’’ by different 
specific interactions such as ion-dipole or/and through the complexation of Ca with chitosan. 
Considering that a dendritic-like structure is formed in the earlier stage of composite 
formation, one can explain the complex bimodal distribution of HAp nano-crystallites in the 
chitosan matrix. Inside the dendritic core, the chitosan chains density is much greater than 
outside of them, shown as inter-connection blob regions. We assume that the probability to 
find a certain number of HAp crystallite seeds per a chitosan chain unit is the same, inside and 
outside the dendritic core regions. Since the chitosan chain density is much greater inside the 
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cores, this leads to the conclusion that the higher density of HAp crystallite seeds is located 
inside the dendritic cores. Consequently inside the core favorite the formation of the ‘‘small 
HAp nanocrystallites (their growth is spatially limited) whereas outside the cores, along the 
interconnection regions where the space constraint is not that much limited, ‘‘large’’ HAp 
nanocrystallites are favorized to be formed. Finally, the cluster-like and scattered-like size 
domains are generated in this way, as seen in Fig.4(4) This theoretical model is supported by 
the experimental data, since we could demonstrate that the amount of chitosan in the 
composite can be used to control the HAp nano-crystallite size, otherwise no influence should 
be observed (Rusu et al., 2005). 
 
Figure 4. Sketch of chitosan (CTS) mineralization through nanosized HAp. The main stages in the 
formation of the composite structure are outlined by the theoretical approach, as shown on the left side 
(A). On the right side (B), we present a TEM micrograph a CTS/HAp 50:50wt% composite, which 
emphasizes the dendritic-like structure of sample at this stage of formation (in gel-like form). 
Furthermore, when the excess water is released a solid, rigid composite is obtained. 
An interesting approach was reported by Hu et al., (2004) in which the chitosan hydrogel is 
mineralized via in situ hybridization by the ionic diffusion processes in a controlled manner. 
It should be mentioned that, each approach of those cited above leads to a particular type of 
chitosan/HAp composite materials with respect to their structure and properties. In order to 
prepare such types of composites, we have reported a stepwise co-precipitation method in 
which the pH of the chitosan solution is gradually increased in a stepwise fashion (Ng et al., 
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2008). Biodegradable hydroxyapatite/chitosan-gelatin polymeric biocomposites were 
fabricated by using HA powder and HA filler containing titania powder (10 and 30%) with a 
chitosan and gelatin grafted co-polymeric matrix during copolymerization process (Mohamed 
and Mostafa, 2008). Preparation of a model HAp/CTS (30:70 in mass ratio) nanocomposite 
nanofibers using a two-step method, which involves firstly preparing HAp/CTS 
nanocomposites by a co-precipitation synthesis approach and then fabricating the resultant 
HAp/CTS nanocomposites, aided with a fiber-forming additive–ultrahigh molecular weight 
poly(ethylene oxide), into nanofibers via the electrospinning process (Zhang et al., 2008). 
5.4. Characterization 
The FT-IR spectra show that the two characteristic bands of amide I (1655 cm-1) and amide II 
(1599 cm-1) for chitosan shift to lower wavenumber after being compounded, which suggests 
that interaction must take place between chitosan and n-HA, including hydrogen bonds 
between -NH2 and-OH of n-HA as well as the chelation between -NH2 and Ca++. The more 
shift of these bands to lower wave number, the stronger the hydrogen bonds between these 
groups and also the stronger the interaction between these molecules (Zhang et al., 2005). 
The XRD pattern of precipitated HA shows un-differentiated broad peaks with poor 
crystallinity around the characteristic region. However, the crystallographic structure of 
precipitated HA nano-crystals is more identical with natural bone mineral (biological 
apatite). Hence, the prepared HA nano-crystallites in this investigation have more similarity 
with natural bone mineral in terms of degree of crystallinity and structural morphology. The 
calcined HA exhibited all the characteristic diffracted peaks of stoichiometric HA with 
higher degree of crystallinity. Rising in the calcination temperature shapes the diffracted 
peaks more sharper, which is a good sign for the improvement of crystallinity of 
precipitated HA. The obtained results did not show any peaks corresponding to calcium 
carbonate and calcium oxide and hence suggesting that the ingredients were reacted 
completely and produced a homogeneous HA. The XRD analysis of HA/chitosan 
composites proved that, a broad peak assigned to chitosan at 20° becomes wider and weaker 
with increase of n-HA. It suggests that the addition of n-HA obviously affects the 
crystallinity of chitosan. The characteristic peaks at 25.8° (002) and 39.6° (310) are used to 
calculate the n-HA crystal sizes (Xianmiao et al., 2009). The TGA mass loss of HA\C 
composite increased from 3.3–6.5 mass% as the chitosan concentration increased from 0–2.5 
mass%. The amount of chitosan that adsorbed on HA was 2.8–3.1 mass% based on Carbon–
Hydrogen–Nitrogen (CHN) analysis. The specific surface area of HA increased after aging 
in chitosan acetate gel solutions and attained a high value of 160 m2/g in comparison to 85 
m2/g for untreated HA (Wilson and Hull, 2008). 
The SEM micrograph of precipitated HA (Fig.5a) exhibited nano-sized crystals with almost 
uniform particles size. The HA particles prepared were not only stoichiometric but also 
mono-dispersive and roughly particles were not fused together with other crystals. It can be 
inferred that majority of the particles were of single crystals, regular shape and cleaner 
contours with no agglomeration which are highly beneficial for coating of nano HA onto 
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biomedical implants. On the other hand, composites bone paste (Figs.5b and c) showed 
heterogeneous phases with complete fusion of HA crystallites into chitosan matrix. Major 
changes in the crystal size of composites were monitored as compared to single phase HA 
due to the presence of chitosan macromolecules. The physical appearances of the 
composites are quite different from the starting material and also apparent that ultra-fine 
particles of HA are found to aggregate into large clusters and precipitate in the chitosan 
matrix. One of the possible reason may be due to some of the HA nano-particles might have 
partially dissolved in the acidic chitosan solution that permitting the HA particles more 
easily to penetrate into the chitosan matrix. The particles of composites showed a high 
tendency to agglomerate and hence it can have capability to prevent the particle 
mobilization after post-implantation. Both the SEM pictures (b and c) of composites 
exhibited porous surfaces, but the pores were not uniform. The average pore size was found 
to 105 and 80mm for 5 and 10 wt chitosan composites, respectively. The composites 
containing porous structure on their surfaces will be more beneficial for tissue in-growth 
(Murugan and Ramakrishna, 2004). Also, the TEM micrographs of HA\chitosan =100\5 
(wt\wt) proved that the HA particle size was 100 nm in length and 20-50 nm in width which 
dispersed well in chitosan matrix homogenously (Hu et al., 2004) 
 
Figure 5. SEM photographs of (a) precipitated nano HA; (b) composite with 5% chitosan sol; and (c) 
composite with 10% chitosan sol. 
5.5. Applications 
One of the present trends in implantable applications requires materials that are derived 
from nature. The impetus is twofold. First, such ‘‘natural’’ materials have been shown to 
better promote healing at a faster rate and are expected to exhibit greater compatibility with 
humans. Second, new concepts in implantable medical devices especially tissue engineering 
derived from a combination of biomaterial onto which cells are seeded, require ‘‘temporal’’ 
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features dictating the biomaterial to matrix was progressively resorbed. Therefore, HA or 
other calcium containing materials incorporated into chitosan has been a primary research 
area where orthopedic or bone substitution and periodontal applications were the focus 
(Khor and Lim, 2003). 
5.5.1. Bone substitutes 
Maruyama and Ito, 1996 reported that the strength of chitosan-HA hardened composite was 
comparable to that the cancellous bone derived from tibial eminentia. Pal et al., (1997) 
prepared different varieties of HA in conjunction with chitosan, as binder, to know its 
unique biological behavior in bone bonding. These hybrid materials displayed good blood 
compatibility (Chen et al., 1998). Apatite cement (AC) was almost completely surrounded by 
mature bone at eight weeks. No promotion or production of osteoconductivity was 
observed by chitosan even though it is considered to promote bone formation. Then, they 
concluded that there is enhancement of bone formation (Takechi et al., 2001).  
Chitosan and silk fobroin (SF) together as a complex organic matrix for HA granules were 
employed attempting to obtain a novel composite HA/chitosan–silk fobroin (HA/CTS–SF) 
with good osteoconductivity, enhanced mechanical strength and sufficient formability and 
flexibility. Additionally, chitosan and SF are easily derived from naturally abundant chitin 
and silk cocoon, respectively, which offers a great promise for the potential use of HA/CTS–
SF composite as bone scaffold material. HA/CTS–SF composite was obtained via a simple 
co-precipitation method at room temperature with chitosan and SF serving as a complex 
organic matrix. The inorganic component in the composite is identified as mono-phase 
poorly crystalline HA containing carbonate ions. The chemical interactions between the 
inorganic and organic constituents in the composite, probably take place via the chemical 
bonding between Ca2+ and the amino group of chitosan or the amide bands of SF. The 
involvement of chitosan and SF endows the composite with higher compressive strengths 
compared to pure HA. These findings suggest that HA/ CTS–SF composite may be a 
promising biomaterial for bone in-growth and implant fixation (Wang and Li, 2007). 
A novel bone repair material can be obtained by incorporating carboxymethyl cellulose 
(CMC) into n-HA/CS system. Not only did it compound uniformity by chemical interactions 
and resembled natural bone apatite in composition morphology and size, but also it 
improved the compressive strength compared with n-HA/CS composite and had 
controllable degradation rate via adjusting the CS/CMC weight ratio (Liuyun et al., 2008 ). 
HA can promote the formation of bone-like apatite on its surface. Polymers combined with 
HA are capable of promoting osteoblast adhesion, migration, differentiation and 
proliferation, especially useful for potential applications in bone repair and regeneration. 
HA particles have been incorporated into chitosan matrices to enhance the bioactivity of 
tissue engineering scaffolds for hard tissue regeneration. Therefore, composite membrane of 
HA and chitosan is expected to be a good degradable barrier membrane for guided bone 
regeneration (GBR) technique (Xianmiao et al., 2009).        
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5.5.2. Bone tissue engineering 
The scaffold is a key component of tissue engineering (Langer and Vacanti, 1993). The study 
of inorganic crystal assembly in or on an organic polymer matrix is an important focus of 
bio-mineralization to produce nano composites, which can mimic natural bone. The 3D 
macro porous scaffolds play an important role in the formation of new tissues and provide a 
temporary scaffold to guide new tissue in-growth and regeneration (Nikalson and Langer, 
1997). Chitosan has been proposed to serve as a non-protein matrix for 3D tissue growth. 
Chitosan could provide the biological primer for cell-tissue proliferation and reconstruction. 
One of the most promising features of chitosan is its excellent ability to be processed into 
porous structures for use in cell transplantation and tissue regeneration. In tissue 
engineering, the porous structure of chitosan provides a scaffold for bone cells to grow in 
and seed new bone regeneration. For rapid cell growth, the scaffold must have optimal 
micro architecture such as pore size, shape and specific surface area (Madihally and 
Matthew, 1999).  
In bone tissue engineering, the biodegradable substitutes act as a temporary skeleton inserted 
into the defective sites of skeleton or lost bone sites, in order to support and stimulate bone 
tissue regeneration while they gradually degrade and are replaced by new bone tissue 
(Service, 2000). Chitosan-based scaffolds possess some special properties for use in tissue 
engineering. The major goal in fabricating scaffolds for bone tissue engineering is to 
accurately control pore size and porosity. Porous chitosan structures can be formed by 
freezing and lyophilizing chitosan–acetic acid solutions in suitable moulds (Chow and Khor, 
2000). Bone regeneration research needed to deal with various clinical bone diseases such as 
bone infections, bone tumors and bone loss by trauma (Braddock et al., 2001). To combine the 
osteoconductivity of calcium phosphate and good biodegradability of polymers, composites 
have been developed for bone tissue engineering either by directly mixing the components or 
by a biomimetic approach (Wei and Ma, 2004). Polymer-ceramic composite scaffolds are 
expected to mimic natural bone, in the way that natural bone is also a composite of inorganic 
compounds (calcium phosphates especially substituted carbonated hydroxyapatite) and 
organic compounds (collagen, protein matrix, etc.). The hydroxyapatite–chitosan–alginate 
porous network has been reported and demonstrated to be suitable for bone tissue 
engineering applications using osteoblast cells (Zhao et al., 2003). 
Research advances in bone regeneration in tissue engineering have focused on the 
development of three dimensional (3D) porous scaffolds that can serve as a support, 
reinforce and in some cases organize the tissue regeneration or replacement in a natural way 
(Sachlos et al., 2003). Several studies have been focused on chitosan–calcium phosphates 
(CP) composites for this purpose in bone tissue engineering. Beta-tricalcium phosphate (β-
TCP) and hydroxyapatite (HA) of CP bioceramics are excellent candidates for bone repair 
and regeneration because of their similarity in chemical composition with inorganic 
components of bone (Zhang et al., 2003). Tissue engineering is regarded as an ultimately 
ideal medical treatment for diseases that have been too difficult to be cured by existing 
methods. This biomedical engineering is designed to repair injured body parts and restore 
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their functions by using laboratory-grown tissues, materials and artificial implants. For 
regeneration of failed tissues, this biomedical engineering utilizes three fundamental tools: 
living cell, signal molecules, and scaffold. The choice of chitosan as a tissue support material 
is governed among others by multiple ways by which its biological, physical and chemical 
properties can be controlled and engineered under mild conditions (Krajewska, 2005). The 
3D macro porous scaffolds play an important role in the formation of new tissues and 
provide a temporary scaffold to guide new tissue in-growth and regeneration. The 
fabrication of biodegradable and osteoconductive scaffolds with a 3D interconnected porous 
network has been a formidable challenge. The feasibility of producing cost effective 
organic–inorganic scaffolds for tissue engineering to mimic bone by the diffusion method 
was performed. The porous structure of chitosan scaffold was homogeneously mineralized 
using this technique of apatite formation at room temperature. The mineralized scaffolds 
were found to be non-cytotoxic and better for cell proliferation and growth, as indicated by 
the enzyme activity and protein levels, than un-mineralized scaffold. This suggested that it 
could be used for further osteoconductivity studies. A biodegradable matrix with sufficient 
mechanical strength, optimized architecture and suitable degradation rate, which could 
finally be replaced by newly formed bone, is most desirable (Manjubala et al., 2006). 
Although the chitosan based composite biomaterials need to improve their mechanical 
properties for bone tissue engineering, no doubt that chitosan is a promising candidate 
scaffold material in clinical practice due to the worthiest ability to bind anionic molecules 
such as growth factors, GAG and DNA. Especially, the ability to link chitosan to DNA may 
render this material a good potential as a substrate for gene activated matrices in gene 
therapy application in orthopedics (Kim et al., 2008). 
Shen et al., (2007) performed that with the increase of pH after the addition of ammonia, 
carboxyl groups of citric acid may begin to act as nucleation center for calcium phosphate 
formation. These negatively charged carboxyls in the reaction system can bond Ca2+ strongly 
and thus forms a large scale of local super saturation microenvironment, and strong electric 
field resulted from high concentration of negatively charged carboxyls are favor of the 
interaction that with the most positively charged crystalline plane, so there are many 
nucleation sites in the network of hydrogel template, each point of nucleation can result in 
microcrystal. Here, to our attention, biocompatible citric acid took the place of acetic acid in 
this work because three carboxyl of citric acid could provide more nucleation sites which 
were appropriate to formation of ultra fine nano-sized carbonate apatite. And it has been 
conjectured that appropriate increase of citrate ions can benefit the bone resorption and 
ossification through the formation of dissociated calcium citrate complexes in the 
surrounding body fluid (Rhee and Tanaka, 1999). Each citric acid molecule can provide 
three negatively charged carboxyls which act as nucleation center for calcium phosphate 
formation. Increase of nucleation center can be appropriate to fine crystallites. Furthermore, 
cross-linking chitosan hydrogel was provided with three dimensional network 
microstructures, its compartment effect limited the growth of inorganic mineral particles, so 
the inorganic nano-particles were limited to aggregate in the compartment of the chitosan 
hydrogel template according to orientation of preferential growth of crystal plane. This 
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multiple-order template effect based on multiple-point nucleation of citric acid and 
compartment of hydrogel network had a very obvious mediation in the formation process of 
homogeneous composites (Shen et al., 2007) (Fig.6). In bone tissue engineering, the 
biodegradable scaffold is a temporary template introduced at the defective site or lost bone 
to initiate bone tissue regeneration, while it gradually degrades and is replaced by newly 
formed bone tissue. Finally, an ideal scaffold is characterized by excellent biocompatibility, 
controllable biodegradability, cytocompatibility, suitable microstructure (pore size and 
porosity) and mechanical properties. Additionally, it must be capable of promoting cell 
adhesion and retaining the metabolic functions of attached cells (Thein-Han and Misra, 
2009). 
 
Figure 6. The scheme of formation of homogeneous chitosan/carbonate apatite composite and 3D 
nanocomposite scaffold (Shen et al., 2007). 
5.5.3. In vitro applications 
The process of apatite formation on the bioactive materials in living body could be 
reproduced in simulated body fluid (SBF), which means that in vivo bone bioactivity of a 
material can be predicted by assessing apatite formation on its surface in SBF. They 
confirmed that there are two types of material which inserted into living body. One of them 
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was able to have apatite form on its surface in SBF, and consequently has apatite produced 
on its surface in the living body, and bonds to living bone through this apatite layer. The 
other type was directly bond to living bone without the formation of apatite on their 
surfaces, so examination of apatite formation on the surface of a material in SBF is useful for 
predicting the in vivo bone bioactivity of the material, not only qualitatively but also 
quantitatively (Kokubo and Takadama, 2006). 
5.5.3.1. In simulated body fluid (SBF) 
From SEM photos (Fig.7), it can be known that chitosan in the chitosan /nHA composite 
gradually degraded during the soaking in SBF solution, which resulted in plenty of macro-
and micropores on the surface of and inside the specimens. At the same time, a lot of tiny 
apatite crystals deposited on the surface of the specimens, and till the 8th week, a thin layer of 
bone-like apatite, being highly bioactive was formed. At the first 4 weeks, the degradation 
rate of chitosan was higher than the deposition rate of apatite on the surface of specimens, 
which corresponding to a continuous increase of the rate of weight loss. After that, the 
deposition of apatite is prior to the degradation of chitosan, so the rate of weight loss 
decreased. This was also confirmed by the rate of water adsorption with the degradation of 
chitosan during the specimen’s soaking in SBF solution, a more sponge-like structure was 
formed, which can hold more water. However, with more apatite crystals deposition, some of 
these pores were filled or covered, so water adsorption decreased (Zhang et al., 2005). Kong 
et al., (2006) reported that chitosan/nano-hydroxyapatite composite scaffolds analysis showed 
that after incubation in simulated body fluid on both of the scaffolds (the apatite-coated 
composite scaffolds and apatite-coated chitosan scaffolds), carbonate hydroxyapatite was 
formed. With increasing nano-hydroxyapatite content in the composite, the quantity of the 
apatite formed on the scaffolds increased. Compared with pure chitosan, the composite with 
nano-hydroxyapatite could form apatite more readily during the biomimetic process, which 
suggests that the composite possessed better mineralization activity (Kong et al., 2006). 
 
Figure 7. The SEM images of chitosan/nHA composites after soaking in SBF solutions for (a) 0 week,  
(b) 1week, (c) 4 weeks and (d) 8 weeks, Magn. × 400. 
The swelling properties and degradation behavior proved the stability of hydroxyapatite-
titania/chitosan-gelatin polymeric biocomposites into the media. In-vitro test behavior 
confirmed that the prepared composite enhanced the deposition of Ca++ and P ions onto the 
surface that is in the favor of the formation of apatite layer. FT-IR and SEM-EDAX of 
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copolymer and three composites post-immersion verified the formation of spherical apatite 
particles onto the copolymer surface; therefore, it was expected to enhance the apatite 
nucleation onto the filler composite surface especially hydroxyapatite-titania/chitosan-
gelatin (AK1) composite containing 10% content of titania (Mohamed and Mostafa, 2008). 
5.5.3.2. Bone Tissue engineering (Scaffold) 
Anti-washout scaffold paste could be directly applied to fit complex shapes of bone defects, 
without involving machining as in the case of sintered hydroxyapatite. The synergistic use 
of a reinforcing agent (e.g., chitosan) and a pore-forming agent (e.g., mannitol) in a bone 
graft may be applicable to other tissue engineering materials. In developing strong and 
macro-porous calcium phosphate cement (CPC) scaffolds by incorporating chitosan and 
water-soluble mannitol. The new CPC–chitosan formulation was biocompatible and 
supported the adhesion, spreading, proliferation and viability of osteoblast cells. The cells 
were observed to infiltrate into the pores of the scaffold and establish cell–cell interactions. 
The increased strength and macroporosity of the new apatite scaffold may help facilitate 
bone ingrowth, implant fixation, and more rapid new bone formation (Fig.8) (Hockin et al., 
2005). 
 
Figure 8. The SEM of cell attachment on (A) CPC control and (B) CPC chitosan composite. The cells 
developed cytoplasmic processes with lengths ranging from approximately 20 to 50 mm, and the 
materials exhibited similar cell attachment and cytoplasmic processes development (Hockin et al., 2005).  
Kong et al., (2006) reported that pre-osteoblast cells cultured on the apatite-coated scaffolds 
showed different behavior. On the apatite-coated chitosan/nano-hydroxyapatite composite 
scaffolds cells presented better proliferation than on apatite-coated chitosan scaffolds. The 
cells on composite scaffolds showed a higher alkaline phosphatase activity which suggested 
a higher differentiation level. The results indicated that the addition of nano-hydroxyapatite 
improved the bioactivity of chitosan/nano-hydroxyapatite composite scaffolds. MSCs do not 
appear to be rejected by the immune system, allowing for large-scale production, 
appropriate characterization and testing, and the subsequent ready availability of allogeneic 
tissue repair enhancing cellular therapeutics. Overall it can be said that, for now, MSCs 
present more advantages than other cells and have already been widely used in bone tissue 
engineering. All the superiorities of MSCs encourage us to introduce MSCs into n-HA 
composite scaffolds for tissue engineering application (Wang et al., 2007). 
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The morphology and behavior of bone marrow stem cell (BMSCs) cultured in-vitro with the 
n-HA/chitosan (CS) composite membranes are observed under phase-contrast microscope. 
Fig.9 shows representative phase-contrast micrographs of cell attachment on the membrane 
with a n-HA/CS ratio of 4:6 after culture for 1 day, 7 days and 11 days. At the first day, only 
a few BMSCs are present with the elongated fusing form shape. At 7 days, a large amount of 
cells proliferate and form cell colony. At 11 days, the population of cells increases manifestly 
and cells fully attach to the membrane. Obviously, the n-HA/CS composite membrane has 
no negative effect on the cell morphology, viability and proliferation (Xianmiao et al., 2009).  
 
Figure 9. Phase-contrast micrographs of the BMSCs (denoted as C) attached to n-HA/CS (4:6) 
membrane (denoted as M) after in vitro culture for 1d (a), 7d (b) and 11 d (c). 
In chitosan–nHA scaffolds, the presence of extensive filopodia, flat morphology, and excellent 
spreading in and around the interconnected porous structure, indicated strong cellular 
adhesion and growth (Fig.10e–h). Furthermore, cell density, cell–cell contact, sheet-like 
structure, and formation of extracellular matrix and cytoplasmic extensions were more 
pronounced on the chitosan–nHA surface than on pure chitosan. They believe based on 
Fig.10e–h that the steps involved in the development of sheet-like morphology involves 
clustering of cells and bridge formation between the pore walls with consequent formation of a 
multilayer structure. These steps occurred during early stages in the nano-composite constructs 
in relation to chitosan scaffolds, suggesting that pre-osteoblasts have high affinity to the surface 
of chitosan–nHA composite, which is attributed to its increase surface area and composition. 
Chitosan–nanocrystalline calcium phosphate scaffolds characterized by a relatively rough 
surface and approximately 20 times greater area/unit mass than chitosan scaffold indicated 
increase adsorption of fibronectin and improved cell attachment (Thein-Han and Misra, 2009). 
5.5.4. In-vivo application 
The extracellular matrix (ECM) is a powerful regulator of cell adhesion and indeed cells 
respond to the ECM by means of integrins, which couple the component of the ECM with the 
actin cytoskeleton. This structure thus mediates adhesion to the ECM and therefore to the 
implant material. In this respect, the possibility of bonding osteoinductive polymers such as 
modified chitosan to the ceramic substrate could enhance cell proliferation and consequently 
anchorage to the implant (Mattiolibelmonte et al., 1998). Sections from chitosan coated HA 
implants exhibited an evident mesenchymal reaction between bone and implant with several 
features of osteoinduction. Bone trabeculae penetrating the HA implant were also observed. 
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Figure 10. Scanning electron micrographs illustrating morphology of pre-osteoblasts seeded on high-
MW chitosan (CH) and chitosan–nHA (CH1) scaffolds (Saggital section). Pre-osteoblasts on chitosan 
surface after (a) day 1, (b) day 3, (c) day 7 and (d) day 21 of cell culture; and on chitosan–nHA surface 
after (e) day 1, (f) day 3, (g) day 7 and (h) day 21 of cell culture. EDS spectra for the boxed region in (c) 
and (g) are presented in (i) and (j), respectively, showing the presence of Ca and P. The P peak is 
merged with the Au peak, which is due to conductive gold coating on the sample. 
Sunny et al., (2002) have reported the preparation of HA-chitosan microspheres as potential 
bone and periodontal filling materials. HA powder was mixed with chitosan solution 
followed by paraffin oil, hexane and a surfactant and the microsphere production process 
commenced. Subsequently, glutaraldehyde was added to crosslink chitosan to give spherical 
particles ranging from 125 to 1000 mm. When the chitosan/n-HA composite implanted in 
body using as tissue scaffold, the degradation of chitosan makes room for the growth of new 
bone and then is substituted by new bone completely. It has been reported that chitosan can 
promote nucleation and growth of apatite and calcite crystals as well. Moreover, the surface 
of chitosan is hydrophilic, which can facilitate cell adhesion, proliferation and differentiation 
(Fig. 11). So, the chitosan/n-HA composite, used as bone substitutes, are hopeful to activate 
the regeneration and remodeling of bone tissue (Zhang et al., 2005).  
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Figure 11. (A) SEM of cell infiltration into a macropore. (B) Cell attachment (arrows) to the bottom of a 
pore. (C) Cells inside a large pore near an opening at the bottom of the pore. (D) Cell-cell interactions 
inside a pore (arrow indicates a cell-cell junction). 
The development of suitable three-dimensional scaffold for the maintenance of cellular 
viability and differentiation is critical for applications in periodontal tissue engineering. The 
different ratios of porous nanohydroxyapatite/chitosan (HA/chitosan) scaffolds were 
prepared through a freeze-drying process. The results indicated that the porosity and pore 
diameter of the HA/chitosan scaffolds were lower than those of pure chitosan scaffold. The 
HA/chitosan scaffold containing 1% HA exhibited better cytocompatibility than the pure 
chitosan scaffold. These scaffolds are evaluated in vitro by the analysis of microscopic 
structure, porosity, and cytocompatibility. The expression of type I collagen and alkaline 
phosphatase (ALP) activity are detected with real-time polymerase chain reaction (RT-PCR). 
Human periodontal ligament cells (HPLCs) transfected with enhanced green fluorescence 
protein (EGFP) are seeded onto the scaffolds, and then these scaffolds are implanted 
subcutaneously into athymic mice after implanted in vivo, EGFP transfected with HPLCs) 
not only proliferate but also recruit surrounding tissue to grow in the scaffold. The 
degradation of the scaffold significantly decreased in the presence of HA. This study 
demonstrated the potential of HA/ chitosan scaffold as a good substrate candidate in 
periodontal tissue engineering (Zhang et al., 2007).  
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